SEC Form 4 · accession 0001225208-17-009429
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam H Schechter
Officer — EVP & Pres-Global Human Health
Period of report
May 5, 2017
Accepted (ET)
May 9, 2017 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 114,124 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $63.97 | May 5, 2017 | A | 162,625 | A | May 5, 2018 | May 4, 2027 | Common Stock | 162,625 | 162,625 | D |
Explanation of responses
- F1Holdings include shares acquired in dividend reinvestment transactions.
- F2The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.